Rein Therapeutics, Inc. Operating Lease, Liability, Current
Rein Therapeutics, Inc. (RNTX) had Operating Lease, Liability, Current of $48.00 thousand as of 2023-12-31, per its 10-K filed 2025-04-07.
Financial Statements › Notes
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-04-07
- 2023-12-31: Operating Lease, Liability, Current $48.00K.
- 2022-12-31: Operating Lease, Liability, Current $33.00K.
- 2022-09-30: Operating Lease, Liability, Current $67.00K.
- 2022-06-30: Operating Lease, Liability, Current $100.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2023-12-31 | $48.00K 10-K · filed 2025-04-07 |
| 2022-12-31 | $33.00K 10-K · filed 2024-04-15 |
| 2022-09-30 | $67.00K 10-Q · filed 2022-11-01 |
| 2022-06-30 | $100.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $131.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $93.00K 10-K · filed 2023-03-20 |
| 2021-09-30 | $93.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $93.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $93.00K 10-Q · filed 2021-05-11 |
| 2020-09-30 | $512.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $490.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $468.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $446.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $426.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $406.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $387.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |